Pharmacological inhibition of TRPV2 attenuates phagocytosis and lipopolysaccharide‐induced migration of primary macrophages
British Journal of Pharmacology · 2023-11 · 180 (21) · 2736-2749
DOI: 10.1111/bph.16154 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Pharmacology, online erschienen am 06.07.2023. Verfasst von Rick Raudszus und 9 weiteren Autor:innen. Beteiligte Einrichtung: Rudolf-Boehm-Institute of Pharmacology and Toxicology, Leipzig University, Leipzig, Germany. Hauptthemen laut MEDLINE: Lipopolysaccharides, Macrophages. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Background and Purpose In macrophages, transient receptor potential vanilloid 2 (TRPV2) channel contributes to various cellular processes such as cytokine production, differentiation, phagocytosis and migration. Due to a lack of selective pharmacological tools, its function in immunological processes is not well understood and the identification of novel and selective TRPV2 modulators is highly desirable. Experimental Approach Novel and selective TRPV2 modulators were identified by screening a compound library using Ca 2+ influx assays with human embryonic kidney 293 (HEK293) cells heterologously expressing rat TRPV2. Hits were further characterized and validated with Ca 2+ influx and electrophysiological assays. Phagocytosis and migration of macrophages were analysed and the contribution of TRPV2 to the generation of Ca 2+ microdomains was studied by total internal reflection fluorescence microscopy (TIRFM). Key Results The compound IV2‐1, a dithiolane derivative (1,3‐dithiolan‐2‐ylidene)‐4‐methyl‐5‐phenylpentan‐2‐one), is a potent inhibitor of heterologously expressed TRPV2 channels (IC 50 = 6.3 ± 0.7 μM) but does not modify TRPV1, TRPV3 or TRPV4 channels. IV2‐1 also inhibits TRPV2‐mediated Ca 2+ influx in macrophages. IV2‐1 inhibits macrophage phagocytosis along with valdecoxib and after siRNA‐mediated knockdown. Moreover, TRPV2 inhibition inhibits lipopolysaccharide‐induced migration of macrophages whereas TRPV2 activation promotes migration. After activation, TRPV2 shapes Ca 2+ microdomains predominantly at the margin of macrophages, which are important cellular regions to promote phagocytosis and migration. Conclusions and Implications IV2‐1 is a novel TRPV2‐selective blocker and underline the role of TRPV2 in macrophage‐mediated phagocytosis and migration. Furthermore, we provide evidence that TRPV2 activation generates Ca 2+ microdomains, which may be involved in phagocytosis and migration of macrophages.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Rudolf-Boehm-Institute of Pharmacology and Toxicology, Leipzig University, Leipzig, Germany.
- Institute of Biological and Chemical Systems, Karlsruhe Institute of Technology, Karlsruhe, Germany.
- Institute of Organic Chemistry, Karlsruhe Institute of Technology, Karlsruhe, Germany.
ORCID-Profile: Michael Schaefer, Kerstin Hill
Förderung
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Raudszus, R., Paulig, A., Urban, N., Deckers, A., Gräßle, S., Vanderheiden, S., Jung, N., Bräse, S., Schaefer, M., & Hill, K. (2023). Pharmacological inhibition of TRPV2 attenuates phagocytosis and lipopolysaccharide‐induced migration of primary macrophages. British Journal of Pharmacology, 180(21), 2736-2749. https://doi.org/10.1111/bph.16154
Vancouver
Raudszus R, Paulig A, Urban N, Deckers A, Gräßle S, Vanderheiden S, et al. Pharmacological inhibition of TRPV2 attenuates phagocytosis and lipopolysaccharide‐induced migration of primary macrophages. British Journal of Pharmacology. 2023;180(21):2736-2749. doi:10.1111/bph.16154
BibTeX
@article{Raudszus2023,
author = {Raudszus, Rick and Paulig, Andrea and Urban, Nicole and Deckers, Anke and Gräßle, Simone and Vanderheiden, Sylvia and Jung, Nicole and Bräse, Stefan and Schaefer, Michael and Hill, Kerstin},
title = {Pharmacological inhibition of TRPV2 attenuates phagocytosis and lipopolysaccharide‐induced migration of primary macrophages},
journal = {British Journal of Pharmacology},
year = {2023},
volume = {180},
number = {21},
pages = {2736--2749},
doi = {10.1111/bph.16154}
}
EUVIMED